Can Metoprolol Cause Itching or Skin Reactions?

Metoprolol can cause itching, rashes, and several other skin reactions, though these side effects are uncommon compared to the drug’s more familiar effects on heart rate and blood pressure. The range of possible skin problems goes beyond simple itch and includes conditions like lichenoid dermatitis, psoriasis flare-ups, and contact-type reactions. Most people taking metoprolol never experience skin issues, but if you develop unexplained itching or a rash after starting or adjusting the medication, the drug itself deserves consideration as a possible cause.

The Kinds of Skin Reactions Metoprolol Can Trigger

The skin problems linked to metoprolol and other beta-blockers are not limited to one type. A review of immunologic adverse reactions tied to the beta-blocker drug class identified a surprisingly broad list of dermatologic effects. These include psoriasis triggering and worsening, anaphylaxis, contact dermatitis, alopecia, lichen planus-like eruptions, excessive sweating, Raynaud’s phenomenon (where fingers turn white or blue in cold), and even vitiligo.¹ That is a wide net, and it is worth noting that many of these reactions are rare. But the variety matters because it means skin symptoms from metoprolol do not always look the same. One person might develop an itchy, bumpy rash while another notices dry, scaly patches that resemble psoriasis.

Simple pruritus, the medical term for itching without a visible rash, is among the more commonly reported complaints. It can show up alone or alongside visible changes to the skin. The itch can be mild and localized to one area or widespread enough to disrupt sleep. Because itching has dozens of possible causes, many people and even some clinicians do not immediately connect it to a medication that was prescribed for blood pressure or heart rhythm.

Lichenoid Dermatitis From Metoprolol

One of the better-documented skin reactions is lichenoid dermatitis, a condition where the skin develops flat-topped, itchy, purplish bumps that can look similar to lichen planus, an inflammatory skin disease. In one published case, a 58-year-old man developed a diffuse, pruritic, papular rash roughly three weeks after beginning metoprolol for high blood pressure. A skin biopsy confirmed the diagnosis of a lichenoid drug eruption, and the rash cleared completely after he stopped taking metoprolol and used a short course of topical corticosteroids.²

Lichenoid drug reactions are not unique to metoprolol. They have been reported with many medications, including other blood pressure drugs, antimalarials, and certain antibiotics. What makes these reactions tricky is that they can appear weeks or even months after starting a medication, well past the point where most people would think to blame a new prescription. The three-week window in the published case is fairly typical for drug-induced lichenoid eruptions, but some take longer. If you have been on metoprolol for a while and only recently developed an itchy, bumpy rash, that does not rule out the medication. The immune system can take time to mount the kind of response that produces visible skin changes.

Psoriasis Flare-Ups and New-Onset Psoriasis

Psoriasis is one of the more concerning skin-related side effects of beta-blockers, and it has received dedicated research attention. Beta-blockers, including metoprolol, can worsen existing psoriasis and can even cause new-onset psoriasis in people who have never had it before.³ The reaction is considered rare, but “rare” in clinical terms still means it happens to real people, and if you are one of them, the distinction is not very comforting.

The proposed mechanism involves intracellular calcium changes that affect how skin cells (keratinocytes) proliferate and how certain immune cells behave. Beta-blockers reduce levels of a signaling molecule called cyclic AMP inside cells, which can tip the balance toward the rapid skin-cell turnover and inflammation characteristic of psoriasis. Several inflammatory mediators appear to play a role, and changes to the beta-adrenergic receptor itself, the very receptor that metoprolol blocks, are also thought to contribute.³

For someone who already manages psoriasis, starting metoprolol can be the trigger for a flare that seems to come out of nowhere. And for someone with a family history of psoriasis who has never had symptoms, beta-blocker therapy may be the environmental push that tips things over. If you have psoriasis or a strong family history of it, this is worth discussing with your prescriber before beginning any beta-blocker.

Timing and Onset Patterns

One of the things that makes drug-induced skin reactions hard to pin down is their variable timing. Some reactions, like hives or generalized itching, can appear within hours or days of the first dose. Others take much longer. The lichenoid case described earlier took about three weeks to develop.² Psoriasis flares may take weeks to months. This gap between starting the drug and seeing skin symptoms is the main reason these reactions are often missed or attributed to something else entirely, like a new soap, seasonal allergies, or stress.

A useful clue is whether the skin problem started after any medication change, not just a brand-new prescription. A dose increase of metoprolol, a switch from the short-acting tartrate form to the extended-release succinate form (or vice versa), or even a change in generic manufacturer can sometimes trigger a reaction. Different generic versions of the same drug use different inactive ingredients such as dyes, fillers, and coatings, and some people are sensitive to those components rather than to metoprolol itself. If your skin symptoms appeared after picking up a refill that looks slightly different from your usual pills, a change in inactive ingredients is worth investigating.

How Drug-Induced Skin Reactions Differ From Allergies

People often describe any unexpected skin reaction as an “allergic reaction,” but the immunology is more complicated, and the distinction has practical implications for what you do next. True immediate allergic reactions to beta-blockers, the kind involving hives, throat swelling, and anaphylaxis, do happen but are very unusual. More commonly, beta-blocker skin reactions involve a delayed immune process. In lichenoid reactions, for instance, the immune system’s T-cells attack the lower layer of the skin in a process that unfolds over days to weeks, not minutes.

Why does this matter? Because the type of reaction affects how it is managed. An immediate allergic reaction (think throat tightening, widespread hives within minutes of taking a pill) typically means you should never take that drug again, and your medical record should be flagged with a true allergy. A delayed skin reaction like lichenoid dermatitis or a psoriasis flare is concerning and usually means switching to a different medication, but it may not carry the same level of danger as a true anaphylactic allergy. Your doctor can help sort out which category your reaction falls into, and a dermatologist can confirm the diagnosis with a skin biopsy if there is any doubt.

Photosensitivity Concerns

Another skin-related issue with some medications is photosensitivity, where the drug makes your skin more vulnerable to sunlight and you develop sunburn-like reactions, blisters, or discoloration after UV exposure that would not normally bother you. A large review cataloging drug-induced photosensitivity identified 393 different drugs or drug compounds with some photosensitizing potential, though the strength of evidence varied widely across those agents.⁴

Beta-blockers are not among the highest-risk drug classes for photosensitivity (that distinction belongs more to certain antibiotics, diuretics like hydrochlorothiazide, and nonsteroidal anti-inflammatory drugs). However, since many people on metoprolol also take other cardiovascular medications, the possibility of a combined photosensitizing effect is worth keeping in mind. If you notice unusual sunburn or rash on sun-exposed areas and you are taking metoprolol alongside other heart or blood pressure medications, mention the full list of drugs to your dermatologist or prescriber.

What to Do if You Suspect a Skin Reaction

The first instinct for many people is to stop taking the medication, but with metoprolol and other beta-blockers, abrupt discontinuation can cause rebound effects like a sudden spike in heart rate and blood pressure, or worsening of angina. That makes it especially important not to stop metoprolol on your own without speaking to your prescriber. A supervised taper or switch to an alternative medication is the safer route.

Here is a reasonable approach if you think metoprolol is causing skin symptoms:

Document the rash: Take photos with timestamps. Note when the symptoms started relative to when you began metoprolol or changed doses. This information is more useful to a clinician than a verbal description.
Contact your prescriber: Call or send a message through your patient portal. Describe the symptoms and the timeline. Let them decide whether to adjust the dose, switch to a different beta-blocker, or move to an entirely different class of medication.
Ask about a biopsy: If the rash is persistent or unusual-looking, a dermatologist can perform a skin biopsy. This is a small, quick procedure that can differentiate a drug-induced eruption from other conditions with similar appearances.
Track improvement after stopping: If metoprolol is discontinued, note how long it takes for the skin to clear. Lichenoid eruptions, for example, typically resolve over weeks to a couple of months after the offending drug is removed, sometimes with help from topical steroids.²

Are Some Beta-Blockers Worse Than Others for Skin Reactions?

Metoprolol is not the only beta-blocker linked to skin problems, and the class as a whole carries some dermatologic risk. Propranolol, atenolol, and other members of the family have all been associated with similar types of reactions, including psoriasis exacerbation and lichenoid eruptions.¹ Propranolol, being a non-selective beta-blocker (it blocks both beta-1 and beta-2 receptors), has historically received more attention for psoriasis triggering than metoprolol, which is more selective for beta-1 receptors. But selectivity is not absolute. At higher doses, metoprolol begins to lose some of its beta-1 selectivity, and its skin effects do not appear to be dramatically different in character from those of less selective agents.

That said, individual biology matters a great deal. Some people tolerate one beta-blocker without any skin trouble but react to another, even within the same class. This can be due to differences in how the drugs are metabolized, differences in the inactive ingredients of specific formulations, or idiosyncratic immune responses that no one fully understands. If you developed a skin reaction on metoprolol, your doctor may try switching you to a different beta-blocker, and there is a reasonable chance you will tolerate the substitute without the same skin issues. There is no guarantee, but it is a common and often successful approach.

The Role of Inactive Ingredients and Generic Formulations

Not every skin reaction blamed on metoprolol is actually caused by metoprolol. The active drug is only one component of each pill. Tablets also contain binders, fillers, coatings, and dyes that vary between brand-name and generic versions and even between different generic manufacturers. Dyes like FD&C Blue No. 2 and Yellow No. 10 are well-known triggers of contact-type skin reactions in sensitive individuals. If your skin symptoms started after switching from one manufacturer’s metoprolol to another, or after moving from brand-name Lopressor or Toprol-XL to a generic, the inactive ingredients are a plausible culprit.

Your pharmacist can usually tell you what changed between refills and can provide the full inactive ingredient list for your specific tablets. In some cases, requesting a specific manufacturer’s version (or asking to try a different generic) resolves the skin problem entirely without needing to abandon metoprolol. This is an underappreciated option that can save you from an unnecessary medication switch.

When Itching on Metoprolol Is Not About the Skin at All

It is worth mentioning that not all itching in a person taking metoprolol is a skin reaction. Metoprolol can affect peripheral circulation, and some people experience mild Raynaud’s-type symptoms, where reduced blood flow to the extremities creates sensations that include tingling, coolness, and sometimes itch-like feelings in the fingers and toes.¹ This is a circulatory phenomenon, not a dermatologic one, and the approach to managing it is different. If your itching is concentrated in your hands and feet and worsens with cold exposure, that pattern points more toward a vascular effect than a skin allergy.

Additionally, metoprolol can cause fatigue and changes in sleep quality, and chronic tiredness can lower the itch threshold for pre-existing skin conditions like eczema or dry skin. In these cases, the drug is not directly causing a skin reaction but is indirectly making a background condition more noticeable. Moisturizing, adjusting room humidity, and treating the underlying dry skin may help without requiring a medication change.

Reporting Skin Reactions

If you experience a skin reaction that you and your doctor believe is linked to metoprolol, reporting it to the FDA’s adverse event system (MedWatch) contributes to the pharmacovigilance data that helps track how common these reactions really are. Drug labels list known side effects based partly on clinical trial data and partly on post-marketing reports from real-world use. Skin reactions from beta-blockers are probably underreported because they are often mild, delayed in onset, and attributed to other causes. Formal reports, even for mild reactions, help build a clearer picture of how often these events actually occur and whether certain formulations or doses carry higher risk. Your doctor can file the report, or you can submit one directly through the FDA’s online portal.

1
PubMed Central. Immunologic adverse reactions of β-blockers and the skin
2
PubMed Central. Metoprolol-induced lichenoid dermatitis
3
PubMed Central. Mechanisms of Beta-Blocker Induced Psoriasis, and Psoriasis De Novo at the Cellular Level
4
PubMed Central. Drug-induced photosensitivity: culprit drugs, potential mechanisms and clinical consequences